Dennis Goldberg

Inquirer
DISC Type : cd

Chief Executive Officer at Senex Biotechnology, Inc.

Maynard, Massachusetts, United States

Overview

Dennis Goldberg is the CEO of Senex Biotechnology, an experienced drug development expert with a Ph. D. from Temple University. He has a track record of leading biotech firms and was instrumental in developing RenaGel and WelChol. Colleagues describe him as a decisive leader with great technical expertise and strong strategic planning skills.

Outside of his professional work, Dennis shows an interest in societal themes and social justice, reflecting on the messages in dystopian films like "Elysium" and sharing historical quotes about collective responsibility. He appears to be a thoughtful individual concerned with broader human issues beyond science.

Unique fact: He has successfully developed and licensed antibodies for treating prostate cancer and products for acute coronary syndrome.

Personality Overview

Upfront

Hard To Convince

Judgemental

They care equally about the product and its potential impact.  They don’t always try to control the conversation but neither do they like yielding it fully. They can be nudged to make faster decisions by offering what they value.

Topics They Care About

Cancer Therapeutics
As CEO of Senex, he leads the development of treatments targeting cancer drug resistance, recently securing multiple international patents for the company's compounds.
Biotech Entrepreneurship
He has extensive experience founding and leading multiple early-stage biotech and pharmaceutical companies, including Luciole Pharmaceuticals and Benu BioPharma.
Drug Development
His career is focused on the end-to-end product development lifecycle, including clinical research, regulatory affairs, and licensing.

Media Appearances

Dennis has no verified media appearances

Work History

6-2022
Chief Executive Officer at Senex Biotechnology, Inc.
3-2020
President and CEO at Luciole Pharmaceuticals, Inc.
10-2009 - 9-2022
President and Founder at Benu BioPharma, Inc
3-2010 - 3-2020
President, CEO and Director at LipimetiX Development Inc.
8-2014 - 7-2017
Director, VP Product Development and Regulatory Affairs at eXIthera Pharmaceuticals Inc.

Education

1977 - 1981
Ph.D. from Temple University
1970 - 1973
M.A from University of Missouri

More Information

Social Presence :

Prographics :

Exp : 13 Location : Maynard, Massachusetts, United States Job Level : Leadership Designation : Chief Executive Officer at Senex Biotechnology, Inc.
URL has been copied!

Insights For Selling To Dennis

During A Call Or A Meeting

DO's

  • Be crisp while making the pitch
  • Highlight the competitive differentiation of your product
  • Tell them that you are there to help them create visible impact within their organization

DONT's

  • Avoid repeating yourself or making generalizations
  • Do not give up if they are not convinced, try again with a different approach
  • Don't try too hard to get friendly, let it happen with time

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Dennis is

  • Confidence in the product plays an important role, followed by powerful testimonials.
  • Will you ever get a clear answer from Dennis

  • They might hesitate a little, but they will say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will Dennis move?

  • Their decision making speed is somewhere in the middle.
  • Can Dennis take some risk or not?

  • Once they have analyzed the pros and cons, they can take some risks.

You And Dennis

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.